안지오텐신 전환효소활성 저해에 의해 항고혈압 효과를 갖는 신품종 감자 구이밸리 추출물
This study was attempted to investigate the anti-hypertensive activity of Solanum tuberosum, cv. Gui valley. Ethanol extract of Gui vally (EGV) increased free radical scarvenge activity up to 91.6% of control at 200 ㎍/㎖. It's anti-oxidant activity is similar to 10 uM of ascorbic acid, well know...
Saved in:
Published in | 동의생리병리학회지 Vol. 23; no. 1; pp. 93 - 96 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | Korean |
Published |
한의병리학회
01.02.2009
|
Subjects | |
Online Access | Get full text |
ISSN | 1738-7698 2288-2529 |
Cover
Summary: | This study was attempted to investigate the anti-hypertensive activity of Solanum tuberosum, cv. Gui valley. Ethanol extract of Gui vally (EGV) increased free radical scarvenge activity up to 91.6% of control at 200 ㎍/㎖. It's anti-oxidant activity is similar to 10 uM of ascorbic acid, well known as antioxidant. EGV inhibited Angiotensin-I-converting enzyme (ACE) activity in vitro. ACE plays a important role in regulation of blood pressure and ACE inhibitors are important for the treatment of hypertension. Anti-hypertensive activity of EGV in vivo was assessed in lead acetate (LAT)-induced hypertensive rats for 8 weeks. Elevated blood pressure in control group was significantly decreased by EGV at 200 mg/kg. Also, ACE activity in blood was also suppressed by EGV treatment. Taken together, these results suggest that EGV has an anti-hypersive activiy via inhibition of ACE and can be used for the treatment or prevention of hypertension. This study was attempted to investigate the anti-hypertensive activity of Solanum tuberosum, cv. Gui valley. Ethanol extract of Gui vally (EGV) increased free radical scarvenge activity up to 91.6% of control at 200 ㎍/㎖. It's anti-oxidant activity is similar to 10 uM of ascorbic acid, well known as antioxidant. EGV inhibited Angiotensin-I-converting enzyme (ACE) activity in vitro. ACE plays a important role in regulation of blood pressure and ACE inhibitors are important for the treatment of hypertension. Anti-hypertensive activity of EGV in vivo was assessed in lead acetate (LAT)-induced hypertensive rats for 8 weeks. Elevated blood pressure in control group was significantly decreased by EGV at 200 mg/kg. Also, ACE activity in blood was also suppressed by EGV treatment. Taken together, these results suggest that EGV has an anti-hypersive activiy via inhibition of ACE and can be used for the treatment or prevention of hypertension. KCI Citation Count: 0 |
---|---|
Bibliography: | G704-000534.2009.23.1.018 |
ISSN: | 1738-7698 2288-2529 |